Form 4 for ARTV Artiva Biotherapeutics, Inc.
Accepted 2026-02-18 00:00:00 ET · period of report 2026-02-15 · accession 0001193125-26-057669 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-18 | 2026-02-15 | ARTV | Bush Jennifer | COO, CLO, Secy, Compliance Off | A - Grant | $0.00 | +117.3K | 350.2K | +50% | $0 | |
| 2026-02-18 | 2026-02-15 | ARTV | Bush Jennifer | COO, CLO, Secy, Compliance Off | F - Tax | $4.00 | -3,515 | 346.7K | -1% | -$14.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-15 | A | A | 117,300 | $0.00 | 350,225 | D | — | — | (F1) Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan. |
| 2 | Common | Common Stock | 2026-02-15 | F | D | 3,515 | $4.00 | 346,710 | D | — | — | (F2) Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards. |